Annals ofArterial Hypertension

Volume: 3 - Number: 30 - September 15, 2003

Outstanding

Meta-analysis: keys to interpret a controversial research tool

Incidence of electrocardiographic alterations in arterial hypertension. MINACOR Study

Pulse pressure as a cardiovascular risk marker

Extraparenchymal renal artery aneurysms. Surgical results and impact hypertension

Cases Reports

Diffuse aneurismatic disease and arterial hypertension: fibromuscular dysplasia

Coartation of aorta in adult patients

Refractory hypertension due to psychogenic causes

White coat normotension as cause of a transitory isquemic accident

Hipertrofia and obstructive hypertrophic cardiomyopathy

Editorial

Electrocardiographic alterations in arterial hypertension

Primary hyperaldosteronism: subsets and diagnosis of location

Optimal treatment of diabetic hypertensives

Clinical adaptation to the international guidelines in hypertension

Anti-hypertensive treatment and rationalization of health expenditures

Image Diagnosis

Cholesterol athero-embolism

Original

Evaluation of the antihypertensive efficacy of amlodipino versus nifedipine-GITS,using noninvasive 24 hours ambulatory blood pressure monitoring in patients with mild to moderate hypertension

Effect of aluminum magnesium hydroxide in pharmacokinetics of irbesartan

Incidence of electrocardiographic alterations in arterial hypertension. MINACOR Study

Pulse pressure as a cardiovascular risk marker

Do we control blood pressure in our diabetic patients? (Evolution 1995-2000)

Upper normal limits of ambulatory blood pressure monitoring: correlation with pulse pressure and microalbuminuria

Cardiovascular risk groups and adequacy of the pharmacological treatment in advanced-aged hypertense population

Extraparenchymal renal artery aneurysms. Surgical results and impact hypertension

Design of a multiparametric risk model of microvascular events in the diabetic type 2 patient by means of multiple logistical regression

Differences in arterial blood pressure between working days and public holidays using automated devices for domiciliary AP self-measurement

Variability and cost of anti-hypertensive treatment

Reviews and Trials

The new cardiovascular risk factors

Role of angiotensin II receptor antagonists in heart failure

Menopause and cardiovascular disease

Meta-analysis: keys to interpret a controversial research tool

Eprosartan in the treatment of hypertension

Cardiovascular risk associated to chronic renal failure

Relevance of smoking in the development of vascular damage in diabetes mellitus

Role of the sympathetic nervous system in the pathogenesis of arterial hypertension